Kangmei Pharmaceutical Co., Ltd. Sustainability Profile
Kangmei Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the development, manufacturing, and distribution of traditional Chinese medicine and modern pharmaceuticals. Kangmei's core offerings include herbal extracts, health supplements, and innovative drug formulations, distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, including recognition for its advanced research and development capabilities, positioning it as a trusted name in the market. With a strong focus on integrating traditional practices with modern science, Kangmei continues to enhance its market presence and contribute to the global healthcare landscape.
DitchCarbon Score
How does Kangmei Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kangmei Pharmaceutical Co., Ltd.'s score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kangmei Pharmaceutical Co., Ltd.'s reported carbon emissions
Kangmei Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Kangmei Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, Kangmei Pharmaceutical's absence of emissions data and reduction initiatives may reflect a broader trend within the sector, where companies are under pressure to enhance transparency and accountability regarding their environmental impact. Without specific emissions data or targets, it is challenging to assess the company's climate commitments or performance relative to industry standards.
How Carbon Intensive is Kangmei Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Kangmei Pharmaceutical Co., Ltd.'s Location?
Kangmei Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kangmei Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
